Abstract
This study examines the relationships of depression, anxiety, and stress with adherence to self-management behaviors and diabetes measures in 42 African American adults with type 2 diabetes (T2D). Participants were recruited from an outpatient clinic located in an urban area of a midsized city in the southeastern USA. The mean age of the sample was 54.9 years (SD = 9.9) and the majority of the participants were female (73.2%), high school graduates (55.3%), unemployed (70.7%), and publicly insured (77.8%). Each participant completed a demographic survey and the Depression, Anxiety and Stress Scale 21. Adherence to self-management behaviors (physical activity, diet, and medication use) was assessed using surveys and self-reports. Glycated hemoglobin (A1c) and body mass index (BMI) were obtained from participants’ medical records at the time of the participants’ clinic visits. Depression, anxiety, and stress were not significantly correlated with self-management behaviors. Depression (r = 0.38, p = 0.03), anxiety (r = 0.56, p = 0.001), and stress (r = 0.36, p = 0.04) were positively correlated with A1c. The greater the dietary risk assessment score, the higher the A1c (r = 0.34, p = 0.05). Anxiety was the strongest correlate of A1c followed by depression, stress, and dietary risk assessment. Future studies to confirm this study’s findings in a larger sample are warranted. Interventions to mitigate the effects of these correlates should be designed and tested to improve health outcomes in African American adults with T2D.
Similar content being viewed by others
References
American Diabetes Association. Statistics about diabetes. 2017. http://www.diabetes.org/diabetes-basics/statistics/. Accessed 20 December 2017.
Centers for Disease Control and Prevention. National diabetes statistics report: estimates of diabetes and its burden in the United States, 2017. 2017. Atlanta, GA: US Department of Health and Human Services.
American Diabetes Association. Facts about type 2. 2017. http://www.diabetes.org/diabetes-basics/type-2/facts-about-type-2/. Accessed 20 December 2017.
Chlebowy DO, Garvin BJ. Social support, self-efficacy, and outcome expectations impact on self-care behaviors and glycemic control in Caucasian and African American adults with type 2 diabetes. Diabetes Educ. 2006;32(5):777–86.
American Diabetes Association. American Diabetes Association® and American Association of Diabetes Educators Issue. 2017 National standards for diabetes self-management education and support. 2017. http://www.diabetes.org/newsroom/press-releases/2017/american-diabetes-association-aade-dsmes-standards-2017.html. Accessed 20 December 2017.
World Health Organization. Depression: let’s talk. 2018. http://www.who.int/mental_health/management/depression/en/.Accessed 19 February 2018.
Zanoveli JM, Morais H, Dias IC Schreiber AK, Souza CP, Cunha JM. Depression associated with diabetes: from pathophysiology to treatment. Curr Diabetes Rev. 2016;12(3):165–78.
Katon WJ, Russo JE, Heckbert SR, Lin EH, Ciechanowski P, Ludman E, et al. The relationship between changes in depression symptoms and changes in health risk behaviors in patients with diabetes. Int J Geriatr Psychiatry. 2010;25(5):466–75.
Williams DR, González HM, Neighbors H, et al. Prevalence and distribution of major depressive disorder in African Americans, Caribbean blacks, and non-Hispanic whites: results from the National Survey of American Life. Arch Gen Psychiatry. 2007;64(3):305–15.
Woodward AT, Taylor RJ, Abelson JM, Matusko N. Major depressive disorder among older African Americans, Caribbean blacks and non-Hispanic whites; secondary analysis of the National Survey of American Life. Depress Anxiety. 2013;30(6):589–97.
Watkins DC, Assari S, Johnson-Lawrence V. Race and ethnic group differences in comorbid major depressive disorder, generalized anxiety disorder, and chronic medical conditions. J Racial Ethn Health Disparities. 2015;2(3):385–94.
Kalyani RR, Ji N, Carnethon M, Bertoni AG, Selvin E, Gregg EW, et al. Diabetes, depressive symptoms, and functional disability in African Americans: the Jackson Heart Study. J Diabetes Complicat. 2017;31(8):1259–65.
Hernandez R, Ruggiero L, Prohaska TR, Chavez N, Boughton SW, Peacock N, et al. A cross-sectional study of depressive symptoms and diabetes self-care in African Americans and Hispanics/Latinos with diabetes: the role of self-efficacy. Diabetes Educ. 2016;42(4):452–61.
Markowitz SM, Gonzalez JS, Wilkinson JL, Safren SA. A review of treating depression in diabetes: emerging findings. Psychosomatics. 2011;52(1):1–18.
Fisher L, Gonzalez JS, Polonsky WH. The confusing tale of depression and distress in patients with diabetes: a call for greater clarity and precision. Diabet Med. 2014;31(7):764–72.
American Psychiatric Association. What are anxiety disorders? 2018. https://www.psychiatry.org/patients-families/anxiety-disorders/what-are-anxiety-disorders. Accessed 19 February 2018.
Engum A. The role of depression and anxiety in onset of diabetes in a large population-based study. J Psychosom Res. 2007;62(1):31–8.
Grigsby AB, Anderson RJ, Freedland KE, Clouse RE, Lustman PJ. Prevalence of anxiety in adults with diabetes: a systematic review. J Psychosom Res. 2002;53(6):1053–60.
Smith KJ, Béland M, Clyde M, Gariépy G, Pagé V, Badawi G, et al. Association of diabetes with anxiety: a systematic review and meta-analysis. J Psychosom Res. 2013;74(2):89–99.
Ruddock S, Fosbury J, Smith A, Meadows K, Crown A. Measuring psychological morbidity for diabetes commissioning. Practical Diabetes International. 2010;27(1):22–6.
Fisher L, Skaff M, Mullan J, Arean P, Glasgow R, Masharani U. A longitudinal study of affective and anxiety disorders, depressive affect and diabetes distress in adults with type 2 diabetes. Diabet Med. 2008;25(9):1096–101.
Bystritsky A, Danial J, Kronemyer D. Interactions between diabetes and anxiety and depression: implications for treatment. Endocrinol Metab Clin N Am. 2014;43(1):269–83.
Bickett A, Tapp H. Anxiety and diabetes: innovative approaches to management in primary care. Exp Biol Med. 2016;241(15):1724–31.
Gois C, Barbosa A, Ferro A, Santos AL, Sousa F, Akiskal H, et al. The role of affective temperaments in metabolic control in patients with type 2 diabetes. J Affect Disord. 2011;134(1):52–8.
Gois C, Dias VV, Raposo JF, do Carmo I, Barbosa A. Vulnerability to stress, anxiety and depressive symptoms and metabolic control in type 2 diabetes. BMC Research Notes. 2012;5(1):271.
Edwards LE, Mezuk B. Anxiety and risk of type 2 diabetes: evidence from the Baltimore epidemiologic catchment area study. J Psychosom Res. 2012;73(6):418–23.
Hall PA, Rodin GM, Vallis TM, Perkins BA. Is there a relationship between medication compliance and quality of life in type 2 diabetes mellitus? J Psychosom Res. 2009;67(4):297–305.
Batscha C. & Gill J. Recognizing and managing stress. In E. Yearwood & V. Hines-Martin (Eds.) Routledge handbook of global mental health nursing: evidence, practice and empowerment. Routledge International Handbooks. 2017. New York: Routledge.
Morris T, Moore M, Morris F. Stress and chronic illness: the case of diabetes. J Adult Dev. 2011;18:70–80. https://doi.org/10.1007/s10804-010-9118-3.
Reader B, Jarrett B, McKim D, Wohleb E, Godbout J, Sheridan J. Peripheral and central effects of repeated social defeat stress: monocyte trafficking, microglial activation, and anxiety. Neuroscience. 2015;289C:429–42. https://doi.org/10.1016/j.neuroscience.2015.01.001.
Kelly S, Ismai M. Stress and type 2 diabetes: a review of how stress contributes to the development of type 2 diabetes. Annu Rev Public Health. 2015;36:441–62.
Osborn C, Mayberry L, Wagner J, Welch G. Stressors may compromise medication adherence among adults with diabetes and low socioeconomic status. West J Nurs Res. 2014;36(9):1091–110.
Lovibond SH, Lovibond PF. Manual for the depression anxiety & stress scales. 2nd ed. Sydney: Psychology Foundation; 1995.
Blair SN, Haskell WL, Ho P, Paffenbarger RS Jr, Vranizan KM, Farquhar JW, et al. Assessment of habitual physical activity by a seven-day recall in a community survey and controlled experiments. Am J Epidemiol. 1985;122:794–804.
Ammerman A, Haines P, DeVellis R, Strogatz D, Keyserling T, Simpson R, et al. A brief dietary assessment to guide cholesterol reduction in low income individuals: design and validation. J Am Diet Assoc. 1991;91:1385–90.
Gomez R, Summers M, Summers A, Wolf A, Summers J. Depression Anxiety Stress Scales-21: measurement and structural invariance across ratings of men and women. Assessment. 2014;21(4):418–26. https://doi.org/10.1177/1073191113514106.
Gloster AT, Rhoades HM, Novy D, Klotsche J, Senior A, Kunik M, et al. Psychometric properties of the Depression Anxiety and Stress Scale-21 in older primary care patients. J Affect Disord. 2008;110(3):248–259.38.
Norton PJ. Depression Anxiety and Stress Scales (DASS-21): psychometric analysis across four racial groups. Anxiety Stress Coping. 2007;20(3):253–65. https://doi.org/10.1080/10615800701309279.
Osborn CY, Mayberry LS, Wagner JA, Welch GW. Stressors may compromise medication adherence among adults with diabetes and low socioeconomic status. West J Nurs Res. 2014;36(9):1091–110.
Kok JL, Williams A, Zhao L. Psychosocial interventions for people with diabetes and co-morbid depression. A systematic review. Int J Nurs Stud. 2015;52(10):1625–39.
Bystritsky A, Kronemyer D. Stress and anxiety: counterpart elements of the stress/anxiety complex. Psychiatr Clin N Am. 2014;37(4):489–518.
Fisher EB, Chan JC, Nan H, Sartorius N, Oldenburg B. Co-occurrence of diabetes and depression: conceptual considerations for an emerging global health challenge. J Affect Disord. 2012;142(Suppl. 2012):S56–66.
Bomyea J, Lang A, Craske MG, Chavira DA, Sherbourne CD, Rose RD, et al. Course of symptom change during anxiety treatment: reductions in anxiety and depression in patients completing the Coordinated Anxiety Learning and Management program. Psychiatry Res. 2015;229(1–2):133–42.
Campbell-Sills L, Sherbourne CD, Roy-Byrne P, Craske MG, Sullivan G, Bystritsky A, et al. Effects of co-occurring depression on treatment for anxiety disorders: analysis of outcomes from a large primary care effectiveness trial. J Clin Psychiatry. 2012;73(12):1509–16.
Baumeister H, Hutter N, Bengel J. Psychological and pharmacological interventions for depression in patients with diabetes mellitus: an abridged Cochrane review. Diabet Med. 2014;31(7):773–86.
Funding
The authors acknowledge the University of Louisville School of Nursing for funding of this study. The authors also thank the staff at the clinic who supported the implementation of this study.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Chlebowy, D.O., Batscha, C., Kubiak, N. et al. Relationships of Depression, Anxiety, and Stress with Adherence to Self-Management Behaviors and Diabetes Measures in African American Adults with Type 2 Diabetes. J. Racial and Ethnic Health Disparities 6, 71–76 (2019). https://doi.org/10.1007/s40615-018-0500-3
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40615-018-0500-3